Oragenics Inc OGEN under CEO (Interim) Janet Huffman
February 25, 2025 by
Moleculin Biotech Inc MBRX under CEO Walter Klemp
February 25, 2025 by
Zymeworks Inc ZYME under CEO Kenneth Galbraith
February 13, 2025 by
Incannex Healthcare Inc IXHL under CEO Joel Latham
February 13, 2025 by
HCW Biologics Inc HCWB under CEO Hing Wong
February 13, 2025 by
GlucoTrack Inc GCTK under CEO Paul Goode
February 13, 2025 by
Phio Pharmaceuticals Corp PHIO under CEO Robert Bitterman
January 29, 2025 by
OncoCyte Corp OCX under CEO Joshua Riggs
January 29, 2025 by
Goldman Sachs GS under CEO David Solomon (repeat 5 years)
January 29, 2025 by
